This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Miyarisan Pharmaceutical Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Jiro Nakayama: Innovator in Peptide Research
Introduction
Jiro Nakayama is a prominent inventor based in Fukuoka, Japan. He has made significant contributions to the field of peptide research, particularly in the development of solutions to combat health issues caused by certain bacteria.
Latest Patents
Jiro Nakayama holds a patent for a cyclic peptide that inhibits the production of toxins by bacteria belonging to the genus Clostridium. This invention aims to provide a means for preventing, treating, and controlling health damages, including food poisoning and infections. The cyclic peptide contains the sequence Cys-Phe-Trp-Ala-His, which is crucial for its effectiveness.
Career Highlights
Throughout his career, Nakayama has focused on innovative approaches to health-related challenges. His work has led to advancements in the understanding of peptide functions and their applications in medicine. He is associated with Miyarisan Pharmaceutical Co., Ltd., where he continues to contribute to research and development.
Collaborations
Jiro Nakayama has collaborated with notable colleagues, including Tohru Shimizu and Kaori Ohtani. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Jiro Nakayama's work in peptide research exemplifies the impact of innovation in addressing health challenges. His contributions continue to pave the way for advancements in medical science and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile